BREWIN DOLPHIN LTD - AVIRAGEN THERAPEUTICS INC ownership

Quarter-by-quarter ownership
BREWIN DOLPHIN LTD ownership history of AVIRAGEN THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$4,376
-69.2%
7,728
-62.8%
0.00%
-50.0%
Q3 2017$14,22320,7600.00%
Other shareholders
AVIRAGEN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 2,836,326$1,848,0000.60%
SENZAR ASSET MANAGEMENT, LLC 1,725,176$1,125,0000.28%
Broadfin Capital, LLC 3,179,226$2,072,0000.25%
Stonepine Capital Management, LLC 314,421$205,0000.12%
TOWERVIEW LLC 180,000$117,0000.06%
GABELLI & Co INVESTMENT ADVISERS, INC. 224,477$146,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 204,470$133,0000.00%
Renaissance Technologies 713,005$465,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 79,796$52,0000.00%
WEDBUSH SECURITIES INC 10,500$7,0000.00%
View complete list of AVIRAGEN THERAPEUTICS INC shareholders